Non–Invasive Prenatal Testing Market - Global Professional Analysis and Forecast to 2026

Oct 24, 2019  |  152 PAGES  |  REPORT CODE: CMM222904
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Non–Invasive Prenatal Testing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 12.3% during the forecast period.

This report presents the market size and development trends by detailing the Non–Invasive Prenatal Testing market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Non–Invasive Prenatal Testing market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Non–Invasive Prenatal Testing industry and will help you to build a panoramic view of the industrial development.

Non–Invasive Prenatal Testing Market, By Type:

  • Ultrasound Detection

  • Biochemical Screening tests

  • Cell-free DNA in Maternal Plasma Tests

  • Fetal Cells in Maternal Blood Tests

Non–Invasive Prenatal Testing Market, By Application:

  • Diagnostic Laboratories

  • Hospitals

Some of the leading players are as follows:

  • Pacific Biosciences of California, Inc. (U.S.)

  • PerkinElmer, Inc. (U.S.)

  • GE Healthcare (U.S.)

  • Illumina, Inc. (U.S.)

  • Agilent Technologies, Inc. (U.S.)

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Koninklijke Philips N.V. (Netherlands)

  • Thermo Fisher Scientific, Inc. (U.S.)

  • Beijing Genomics Institute (China)

  • QIAGEN N.V. (Germany)

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Non–Invasive Prenatal Testing Market: Technology Type Analysis

  • 4.1 Non–Invasive Prenatal Testing Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Non–Invasive Prenatal Testing Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Ultrasound Detection

    • 4.3.2 Biochemical Screening tests

    • 4.3.3 Cell-free DNA in Maternal Plasma Tests

    • 4.3.4 Fetal Cells in Maternal Blood Tests

5 Non–Invasive Prenatal Testing Market: Product Analysis

  • 5.1 Non–Invasive Prenatal Testing Product Market Share Analysis, 2018 & 2026

  • 5.2 Non–Invasive Prenatal Testing Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Non–Invasive Prenatal Testing Market: Application Analysis

  • 6.1 Non–Invasive Prenatal Testing Application Market Share Analysis, 2018 & 2026

  • 6.2 Non–Invasive Prenatal Testing Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Diagnostic Laboratories

    • 6.3.2 Hospitals

7 Non–Invasive Prenatal Testing Market: Regional Analysis

  • 7.1 Non–Invasive Prenatal Testing Regional Market Share Analysis, 2018 & 2026

  • 7.2 Non–Invasive Prenatal Testing Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Pacific Biosciences of California, Inc. (U.S.)

    • 9.1.1 Pacific Biosciences of California, Inc. (U.S.) Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 PerkinElmer, Inc. (U.S.)

    • 9.2.1 PerkinElmer, Inc. (U.S.) Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 GE Healthcare (U.S.)

    • 9.3.1 GE Healthcare (U.S.) Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Illumina, Inc. (U.S.)

    • 9.4.1 Illumina, Inc. (U.S.) Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Agilent Technologies, Inc. (U.S.)

    • 9.5.1 Agilent Technologies, Inc. (U.S.) Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 F. Hoffmann-La Roche Ltd. (Switzerland)

    • 9.6.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Koninklijke Philips N.V. (Netherlands)

    • 9.7.1 Koninklijke Philips N.V. (Netherlands) Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Thermo Fisher Scientific, Inc. (U.S.)

    • 9.8.1 Thermo Fisher Scientific, Inc. (U.S.) Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Beijing Genomics Institute (China)

    • 9.9.1 Beijing Genomics Institute (China) Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 QIAGEN N.V. (Germany)

    • 9.10.1 QIAGEN N.V. (Germany) Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 89 Figures and 129 Tables)

  • Figure Ultrasound Detection Non–Invasive Prenatal Testing market, 2015 - 2026 (USD Million)

  • Figure Biochemical Screening tests Non–Invasive Prenatal Testing market, 2015 - 2026 (USD Million)

  • Figure Cell-free DNA in Maternal Plasma Tests Non–Invasive Prenatal Testing market, 2015 - 2026 (USD Million)

  • Figure Fetal Cells in Maternal Blood Tests Non–Invasive Prenatal Testing market, 2015 - 2026 (USD Million)

  • Figure Diagnostic Laboratories market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Non–Invasive Prenatal Testing market, by country, 2015 - 2026 (USD Million)

  • Table North America Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table North America Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table North America Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Canada Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Canada Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Europe Non–Invasive Prenatal Testing market, by country, 2015 - 2026 (USD Million)

  • Table Europe Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Europe Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Europe Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Germany Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Germany Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table France Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table France Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Italy Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Italy Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Spain Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Spain Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non–Invasive Prenatal Testing market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table China Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table China Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Japan Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Japan Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table India Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table India Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Non–Invasive Prenatal Testing market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table MEA Non–Invasive Prenatal Testing market, by country, 2015 - 2026 (USD Million)

  • Table MEA Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table MEA Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table MEA Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Non–Invasive Prenatal Testing market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Non–Invasive Prenatal Testing market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Non–Invasive Prenatal Testing market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Pacific Biosciences of California, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PerkinElmer, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GE Healthcare (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Illumina, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Agilent Technologies, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table F. Hoffmann-La Roche Ltd. (Switzerland) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Koninklijke Philips N.V. (Netherlands) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Fisher Scientific, Inc. (U.S.) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beijing Genomics Institute (China) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table QIAGEN N.V. (Germany) Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top